Journal of Blood Medicine
Volume 13, 2022 - Issue
Open access
102
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Comparison of Real-World Dose and Consumption for Two Extended Half-Life Recombinant Factor VIII Products for the Treatment of Hemophilia A in the United States
Yanyu Wu1 Global Evidence & Outcomes, Data Sciences Institute, Research and Development, Takeda Development Center Americas, Inc, Cambridge, MA, USACorrespondence[email protected]
View further author information
, View further author information
Shawn X Sun1 Global Evidence & Outcomes, Data Sciences Institute, Research and Development, Takeda Development Center Americas, Inc, Cambridge, MA, USA
https://orcid.org/0000-0002-7949-2145View further author information
Tao Fan2 US Health Economics and Outcomes Research, Takeda Pharmaceuticals USA, Inc, Lexington, MA, USAView further author information
Pages 517-524
|
Received 21 Mar 2022, Accepted 30 Aug 2022, Published online: 24 Sep 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.